Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

VRD-CEP: An Effective and Tolerable Chemo-Mobilization and Debulking Regimen for Multiple Myeloma

Hamza Hashmi, MD, Suresh Manapuram, MD, Timothy C. Baize, PharmD, Lindsay Figg, PharmD, Soumit K. Basu, MD PhD, William Tse, MD, Maxwell M. Krem, MD PhD

Blood (2017) 130 (Supplement 1): 3203.

https://doi.org/10.1182/blood.V130.Suppl_1.3203.3203

Published: 2017

Journal Articles

Weekly Dosing of Bortezomib in RVD Achieves Minimal Toxicity with No Reduction in Efficacy in a Diverse Cohort of Multiple Myeloma Patients

Syed Hussaini, MD, Amitoj Gill, MD, Rahul Gosain, MD, Shesh Rai, PhD, Xiaoyong Wu, Jill Rhodes, Pharm D, Soumit K. Basu, MD PhD, Ju-Hsien Chao, DO, William Tse, MD, Geoffrey P. Herzig, MD, Roger H. Herzig, MD, Maxwell M. Krem, MD PhD

Blood (2017) 130 (Supplement 1): 5425.

https://doi.org/10.1182/blood.V130.Suppl_1.5425.5425

Published: 2017

Journal Articles

Use of a Hemoglobin Substitute (HBOC-201) to Treat Acute Anemia in a Leukemic Patient with Anti-Vel Antibodies

M. Tayyeb Ayyoubi, MD, Suresh Manapuram, MD, Hamza Hashmi, MD, Katherine McDaniel, MLS (ASCP), Soumit K. Basu, MD PhD, William Tse, MD, Maxwell M. Krem, MD PhD

Blood (2017) 130 (Supplement 1): 4928.

https://doi.org/10.1182/blood.V130.Suppl_1.4928.4928

Published: 2017

Journal Articles

Characterization of Mesenchymal Stromal Cells (MSCs) Derived From Acute Myeloid Leukemia (AML) Bone Marrow

Soumit K. Basu, MD, PhD, Xin Zhao, MD, Sylvia Chien, Min Fang, MD, PhD, Vivian Oehler, MD, Pamela S Becker, MD, PhD

Blood (2011) 118 (21): 2558.

https://doi.org/10.1182/blood.V118.21.2558.2558

Published: 2011

Journal Articles

Clinical and Functional Relevance of Interactions Between the Bone Marrow Stormal Microenvironment and Primary Human Acute Myeloid Leukemia (AML) Cells

Soumit K. Basu, MD, PhD, Sylvia Chien, Xin Zhao, MD, Kenneth J. Kopecky, PhD, Frederick R. Appelbaum, MD, Thalia Papayannopoulou, MD, DSci, Elihu H. Estey, MD, Pamela S. Becker, MD, PhD

Blood (2010) 116 (21): 2756.

https://doi.org/10.1182/blood.V116.21.2756.2756

Published: 2010

NARROW

VRD-CEP: An Effective and Tolerable Chemo-Mobilization and Debulking Regimen for Multiple Myeloma

Weekly Dosing of Bortezomib in RVD Achieves Minimal Toxicity with No Reduction in Efficacy in a Diverse Cohort of Multiple Myeloma Patients

Use of a Hemoglobin Substitute (HBOC-201) to Treat Acute Anemia in a Leukemic Patient with Anti-Vel Antibodies

Characterization of Mesenchymal Stromal Cells (MSCs) Derived From Acute Myeloid Leukemia (AML) Bone Marrow

Clinical and Functional Relevance of Interactions Between the Bone Marrow Stormal Microenvironment and Primary Human Acute Myeloid Leukemia (AML) Cells

Email alerts

ASH Publications

American Society of Hematology

VRD-CEP: An Effective and Tolerable Chemo-Mobilization and Debulking Regimen for Multiple Myeloma

Weekly Dosing of Bortezomib in RVD Achieves Minimal Toxicity with No Reduction in Efficacy in a Diverse Cohort of Multiple Myeloma Patients

Use of a Hemoglobin Substitute (HBOC-201) to Treat Acute Anemia in a Leukemic Patient with Anti-Vel Antibodies

Characterization of Mesenchymal Stromal Cells (MSCs) Derived From Acute Myeloid Leukemia (AML) Bone Marrow

Clinical and Functional Relevance of Interactions Between the Bone Marrow Stormal Microenvironment and Primary Human Acute Myeloid Leukemia (AML) Cells

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only